Search
for
Sort by
Research 30 of 1000+
- Cutaneous adverse effects of targeted therapies
- Cutaneous adverse effects of targeted therapies
- Cutaneous adverse effects of BRAF inhibitors in metastatic malignant melanoma, a prospective study in 20 patients.
- Prospective Case Series of Cutaneous Adverse Effects Associated With Dabrafenib and Trametinib
- Diagnosis and treatment of cutaneous adverse effects of targeted therapy, antibody–drug conjugates, and immunotherapy in cancer patients: a national consensus statement by the Spanish Society of Medical Oncology and the Spanish Academy of Dermatology and Venereology
- Cutaneous Adverse Effects of EGFR Therapy in Breast Cancer Treatment
- Cutaneous adverse effects of chemotherapy in cancer patients: A clinico epidemiological study
- Adverse cutaneous effects of psychotropic medications
- Cutaneous adverse reactions linked to targeted anticancer therapies bortezomib and lenalidomide for multiple myeloma: new drugs, old side effects
- A Systematic Review of the Cutaneous Adverse Effects of GLP-1 Agonists
- Cutaneous adverse events to systemic antineoplastic therapies: a retrospective study in a public oncologic hospital
- Dermatological Adverse Effects of Covid-19 Vaccine among Healthcare Workers: Findings from a Tertiary Care Hospital in Northern India
- Dermatologic adverse effect of subcutaneous furosemide administration in a cat
- Adverse Effects Associated with Long-Term Administration of Azole Antifungal Agents
- A Prospective Study of Cutaneous Adverse Events Induced by Low-Dose Alpha-Interferon Treatment for Malignant Melanoma
- Treatment Strategies for Cutaneous and Oral Mucosal Side Effects of Oncological Treatment in Breast Cancer: A Comprehensive Review
- INDIVIDUAL ARTICLE: USCOM V: A Practical Algorithm for the Prevention and Treatment of Cutaneous Side Effects of Hormonal Cancer Therapy
- Cutaneous Toxicities of Advanced Treatment for Cutaneous Melanoma: A Prospective Study from a Single-Center Institution
- Mitigation of epidermal growth factor receptor inhibitor-induced side effects utilizing melanin and vascular-specific lasers: A case report series
- Cutaneous toxicities of new treatments for melanoma
- Cutaneous Adverse Events in Patients with Chronic Hepatitis C during Treatment with Directly Acting Antiviral Agents: A cohort study
- Cutaneous Adverse Events of Tyrosine Kinase Inhibitors in Endocrine Tumors: Clinical Features, Mechanisms, and Management Strategies
- Chemotherapy and the Skin: Understanding Dermatologic Side Effects
- Cutaneous Adverse Events of Targeted Anticancer Therapy: A Review of Common Clinical Manifestations and Management
- Clinical Management of Cutaneous Adverse Events in Patients on Chemotherapy: A National Consensus Statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- Cutaneous Side Effects of Modern Targeted Therapy and Immunotherapy in Patients with Dermatological Malignancies
- The incidence and management of cutaneous adverse events of the epidermal growth factor receptor inhibitors
- Adverse effects of voriconazole: Over a decade of use
- Rare Cutaneous Side Effects of Imiquimod: A Review on Its Mechanisms, Diagnosis, and Management
- Epidermal Growth Factor Receptor Inhibitors: A Review of Cutaneous Adverse Events and Management